| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.23 | 6e-05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |